 | Up a level |
Behrens, Frank, Tak, Paul P., Ostergaard, Mikkel, Stoilov, Rumen, Wiland, Piotr, Huizinga, Thomas W., Berenfus, Vadym Y., Vladeva, Stoyanka 
ORCID: 0000-0001-6457-5178, Rech, Juergen, Rubbert-Roth, Andrea, Korkosz, Mariusz, Rekalov, Dmitriy, Zupanets, Igor A., Ejbjerg, Bo J., Geiseler, Jens, Fresenius, Julia, Korolkiewicz, Roman P., Schottelius, Arndt J. and Burkhardt, Harald
(2015).
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.
Ann. Rheum. Dis., 74 (6).
S. 1058 - 1065.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060